Literature DB >> 6518944

Effect of 'high-dose' amikacin in children.

K M Kumor, J M McDonald, P S Lietman.   

Abstract

17 children with serious infections were treated for an average period of 9.5 days with 420 mg/m2/dose of amikacin every 8 h. The nephrotoxicity and ototoxicity of this 'high-dose' regimen was studied. None of the children had evidence of nephrotoxicity. Of 9 children who could be clearly evaluated, 1 child experienced a delayed transient auditory dysfunction. 1 child experienced delayed serious deafness, but was receiving other ototoxic drugs. Despite the fact that the doses averaged 54.1 mg/kg/day, 5 children in our series had peak concentrations lower than that recommended for adults with serious infection.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6518944     DOI: 10.1159/000457188

Source DB:  PubMed          Journal:  Dev Pharmacol Ther        ISSN: 0379-8305


  1 in total

Review 1.  Aminoglycoside-induced hearing loss in humans.

Authors:  R E Brummett; K E Fox
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.